Optimisation of Care in Vulnerable HIV Infected Individuals
NCT03799276 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200
Last updated 2024-02-02
Summary
Antiretroviral therapy is currently the only way to control HIV disease progression in HIV infected subjects and to prevent transmission. However a sustained virological control through antiretroviral therapy is requested for these objectives. There is currently 8-10% of patients who failed therapy for many reasons other than virological resistance including social unstability, psychiatric disorders, migrant status, drug or alcohol addictions. Because many of these vulnerabilities can be managed and patients helped for following adequately cares and treatments, study team designed the OPTICARE Program to help reduce impact of the patients' vulnerabilities.
The OPTICARE study is designed as a prospective implementation interventional study which aims to improve retention in care among vulnerable HIV infected patients over 48 weeks.
The OPTICARE program is a support program dedicated to patients either lost to follow up or in highly fraility situation that will offer an individualized care management to fill their gaps towards optimized care and control of viral replication. Our aim is, in patients virally failing in relation with poor adherence to care and treatment to test first part whether tracking proactively lost to follow up patients or detecting frail individuals at risk of lost to care is effective and secondly to evaluate the efficacy, the feasibility and the acceptability of an intervention tailored to each individual to get them to treatment success with viral suppression. In our context, a randomized approach would not be seen as ethical or possible in an environment where investigators need to evaluate such intervention as a pilot approach. Investigators therefore enrolled patients in a cohort population study OPTICARE program aim to actively identify vulnerable HIV+ population and promote optimal access to health care to this population using retention in care program in order to enable long term HIV infection control.
The primary objective is to assess the feasability and the effectiveness of the OPTICARE program. The OPTICARE program aims to propose an individualized care to vulnerable HIV infected patients (UNAIDS/Second 90% goal) and to drive them to treatment success (UNAIDS/Third 90% goal) within a one-year period.
Conditions
- HIV Infections
Interventions
- OTHER
-
Opticare study
Each patient will be evaluated by * An HIV physician * A nurse * A social worker * A psychological therapist * A cultural mediator/member of patients community if needed for migrants Following these interviews and visits, a multisciplinary team will define for each patient an individualized OPTICARE program based on the following items: clinical, psychological/psychiatric, social status and follow up visits will be planned with the patient. Regular (Day 15 and monthly) phone calls will be set up during the first six months of the OPTICARE program, to assess the clinical status and ART adherence. Patients will have their medical, biological and social status assessed through visits at W4, W12, W24, W36 (medical and social status only) and W 48 with all members of the OPTICARE team.
Sponsors & Collaborators
-
ViiV Healthcare
collaborator INDUSTRY -
Institut de Sante Publique, d'Epidemiologie et de Developpement
collaborator OTHER -
Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida
lead OTHER
Principal Investigators
-
Sophie Seang, MD · Pitie Salpetriere Hospital
Study Design
- Allocation
- NA
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-01-15
- Primary Completion
- 2022-06-15
- Completion
- 2023-12-15
Countries
- France
Study Locations
More Related Trials
-
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
NCT00537394 ·Status: COMPLETED ·Phase: PHASE3
-
Same-Day HIV Testing and Treatment Initiation to Improve Retention in Care
NCT01900080 ·Status: UNKNOWN ·Phase: NA
-
Efficacy of BIC/F/TAF Versus Standard of Care in the Treatment of New HIV Infection Diagnoses in the Context of 'Test and Treat'
NCT04653194 ·Status: COMPLETED ·Phase: PHASE3
-
Prospective Evaluation Among Patients Infected by HIV 1 in Virological Failure Owing to Lack of Compliance, of the Benefit in Terms of Compliance of an Optimised Antiretroviral Treatment With Enfuvirtide (Fuzeon) Associated With Two Active Molecules
NCT00937729 ·Status: TERMINATED
-
Ex Vivo Characterization and Targeting of the Latent HIV Infected Reservoir to Cure HIV
NCT05215704 ·Status: RECRUITING
-
Cohort of Patients Naive of Antiretroviral Treatment at Enrollment
NCT03137797 ·Status: COMPLETED
-
Research In Viral Eradication of HIV Reservoirs
NCT02336074 ·Status: COMPLETED ·Phase: PHASE2
-
CD4 Cell Recovery in HIV-1 Patients Comparing 2 Treatment Regimes
NCT00966160 ·Status: COMPLETED ·Phase: PHASE3
-
Immune Reconstitution of Lopinavir/Ritonavir-Based vs Efavirenz-based HAART in Advanced HIV Disease
NCT00775606 ·Status: TERMINATED ·Phase: PHASE4
-
VRC-HIVMAB060-00-AB (VRC01) in People With Chronic HIV Infection Undergoing Analytical Treatment Interruption
NCT02471326 ·Status: COMPLETED ·Phase: PHASE1
-
Observational Study of HIV-Infected Subjects With X4-Tropic or Non-Phenotypeable Virus
NCT00321438 ·Status: TERMINATED
-
Lenacapavir Intensification to Disrupt HIV Reservoirs in Virologically Suppressed People With HIV Receiving Antiretroviral Therapy
NCT06819176 ·Status: RECRUITING ·Phase: PHASE1
-
Nevirapine vs Ritonavir-boosted Lopinavir in ART Naive HIV-infected Adults in a Resource Limited Setting
NCT01772940 ·Status: COMPLETED ·Phase: PHASE4
-
Assessment of VAC-3S Therapeutic Properties When Combined With Standard ART in the Course of HIV-1 Infection
NCT02041247 ·Status: UNKNOWN ·Phase: PHASE2
-
Switching the Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI) or Protease Inhibitor (PI) to Maraviroc in HIV Subjects
NCT00966329 ·Status: COMPLETED ·Phase: PHASE4
-
Early Fast-Track Versus Standard Care for Persons With HIV Initiating TLD
NCT04311944 ·Status: UNKNOWN ·Phase: NA
-
A Long-term Follow-up of the HIV-NAT Cohort
NCT00411983 ·Status: RECRUITING
-
Treatment Intensification for HIV Infected Patients With Multi-Drug Resistant Virus
NCT00102934 ·Status: UNKNOWN ·Phase: NA
-
Duration of Dual Antiretroviral Therapy in Virologically Suppressed People Living With HIV and Factors Associated With Switching to Tritherapy : a Real-life Cohort
NCT06107140 ·Status: COMPLETED
-
HIV-1 Infected Patients, Phase II Trial, Dual Combination Doravirine/Raltegravir Open Label
NCT04513626 ·Status: RECRUITING ·Phase: PHASE2
-
Effectiveness of Antiretroviral Therapy During Acute HIV Infection
NCT00705926 ·Status: COMPLETED ·Phase: PHASE1
-
Cognitive Therapy in Patients Failing ART
NCT03751046 ·Status: COMPLETED ·Phase: NA
-
A Study to Provide Continued Access to Study Drug to Children and Adolescents Who Have Completed Clinical Studies Involving Gilead HIV Treatments
NCT06337032 ·Status: RECRUITING ·Phase: PHASE4
-
Implementation of Onsite, Rapid ART Initiation Among People Who Inject Drugs Living With HIV at Syringe Services Program
NCT04650269 ·Status: COMPLETED ·Phase: PHASE4
-
The Late Presenter Treatment Optimisation Study
NCT03696160 ·Status: COMPLETED ·Phase: PHASE3